Articles related to ANTIBIOTICS

The new consensus on urine culture practices emphasizes reducing unnecessary antibiotic use by refining diagnostic criteria and testing protocols, thus supporting robust antimicrobial stewardship.

Zevtera® (ceftobiprole medocaril) provides a significant advancement in treating serious bacterial infections, demonstrating high efficacy against both MRSA and MSSA in recent phase 3 clinical trials.

In a recent clinical observation, a patient treated with dapsone for leprosy exhibited symptoms of methemoglobinemia, despite a normal Pao2 level. Such cases underscore the need for vigilant monitoring of oxygen saturation and methemoglobin levels during dapsone therapy.

In a striking case of syphilitic pharyngitis, a patient’s rare oropharyngeal symptoms prompt a deeper dive into differential diagnoses, emphasizing the critical role of serology and biopsy in confirming syphilis, a common infection with uncommon presentations.

The CODA trial illuminates a pivotal moment in appendicitis management, highlighting antibiotics as a noninferior treatment to appendectomy, which could significantly influence patient outcomes and healthcare resource allocation, especially during public health emergencies like the COVID-19 pandemic.

The recent trial conducted in Burkina Faso, involving over 32,000 infants, demonstrates that targeted azithromycin treatment at routine health visits does not significantly reduce infant mortality, challenging previous beliefs about its effectiveness in individual-level interventions.